The data presented in this manuscript demonstrate significant sEH inhibition and antihypertensive effects of QR so that it may be deployed as a cost-effective, stand-alone, or complementary approach for the treatment of hypertension and the prevention of organ damage induced by uncontrolled high blood pressure. The gene discussed is EPHX2; the disease is Hypertension.